JOVIC, Gordana
JOVIC, Gordana
A prognostic model based on nodal status and Ki-67 predicts the risk of recurrence and death in breast cancer patients with residual disease after preoperative chemotherapy.
2009 Guarneri, Valentina; Piacentini, Federico; Ficarra, G; Frassoldati, A; D'Amico, Roberto; Giovannelli, Simona; Maiorana, Antonino; Jovic, Gordana; Conte, Pierfranco
Biomarker expression and survival after primary chemotherapy for breast cancer.
2006 Guarneri, Valentina; Piacentini, Federico; Jovic, Gordana; Frassoldati, A; Ficarra, G; Giovannelli, Simona; Maur, M; Borghi, F; Vicini, Roberto; Conte, Pierfranco
CHEMOTHERAPY-INDUCED MODULATION OF BIOMARKERS EXPRESSION IN PRIMARY BREAST CANCER PATIENTS TREATED WITH PREOPERATIVE CHEMOTHERAPY
2006 Guarneri, V.; Piacentini, F.; Frassoldati, A.; Jovic, G.; Ficarra, G.; Maur, M.; Giovannelli, S.; Giardina, D.; Conte, P. F.
CHER LOB Trial: Preoperative chemotherapy plus trastuzumab, lapatinib or both in HER2-positive operable breast cancer--Safety report as per Independent Data Monitoring Committee (IDMC) and preliminary activity data
2008 Guarneri, Valentina; A., Frassoldati; K., Cagossi; A., Bottini; A., Michelotti; L., Cavanna; Jovic, Gordana; Piacentini, Federico; C., Oliva; Conte, Pierfranco
CHER-LOB: PREOPERATIVE CHEMOTHERAPY PLUS TRASTUZUMAB, LAPATINIB OR BOTH IN HER2-POSITIVE OPERABLE BREAST CANCER – PRELIMINARY SAFETY REPORT WITH FOCUS ON CARDIAC TOLERABILITY
2007 Guarneri, V.; Frassoldati, A.; Cagossi, K.; Bottini, A.; Cavanna, L.; Michelotti, A.; Jovic, G.; Piacentini, F.; Oliva, C.; Conte, Pf.
Comparison of HER-2 and hormone receptor expression in primary breast cancers and asynchronous paired metastases: impact on patient management
2008 Guarneri, Valentina; Giovannelli, Simona; Ficarra, G; Bettelli, Stefania Raffaella; Maiorana, Antonino; Piacentini, Federico; Barbieri, Elena; Dieci, Maria Vittoria; D'Amico, Roberto; Jovic, Gordana; Conte, Pierfranco
COMPARISON OF HER-2 STATUS IN PRIMARY BREAST CANCER AND METASTATIC SITES: RESULTS FROM A SINGLE INSTITUTION ANALYSIS
2008 Guarneri, V.; Giovannelli, S.; Ficarra, G.; Bettelli, S.; Piacentini, F.; Barbieri, E.; Dieci, Mv.; Jovic, G.; Conte, Pf.
Final results of a phase II, double blind, placebo controlled, randomized trial of preoperative chemotherapy +/- gefitinib with biomarker evaluation in operable breast cancer
2006 Guarneri, Valentina; Frassoldati, A; Ficarra, G; Jovic, Gordana; Puglisi, F; Michelotti, A; Boni, C; Battelli, N; Santoro, A; Conte, Pierfranco
Helicobacter pylori infection andchronic immune thrombocytopenic purpura: long-term results of bacteriumeradication and association with bacterium virulence profiles
2007 Emilia, Giovanni; Luppi, Mario; Zucchini, Patrizia; Morselli, M; Potenza, Leonardo; Forghieri, Fabio; Volzone, F; Jovic, Gordana; Leonardi, G; Donelli, A; Torelli, Giuseppe
LET-LOB: preoperative letrozole plus lapatinib or placebo in hormone-receptor positive HER2 negative operable breats cancer. Preliminary report of activity and cardiac tolerability
2007 Frassoldati, A; Guarneri, Valentina; Cagossi, K.; Bottini, A; Cavanna, L; Jovic, Gordana; Piacentini, Federico; Oliva, C; Conte, Pierfranco
Letrozole Versus Letrozole Plus Lapatinib (GW572016) in Hormone-Sensitive, HER2-Negative Operable Breast Cancer: A Double-Blind, Randomized Phase II Study with Biomarker Evaluation (EGF109077-LAP107692/LETLOB)
2008 Frassoldati, A; Guarneri, Valentina; Piacentini, Federico; Jovic, Gordana; Giovannelli, Simona; Oliva, C; Conte, Pierfranco
Middle turbinate preservation versus middle turbinate resection in endoscopic surgical treatment of nasal polyposis
2008 Marchioni, Daniele; ALICANDRI CIUFELLI, Matteo; Mattioli, Francesco; Marchetti, Alessio; Jovic, Gordana; Massone, Federica; Presutti, Livio
MODULAZIONE DELL’ESPRESSIONE DI BIOMARCATORI E PROGNOSI IN PAZIENTI AFFETTE DA CARCINOMA MAMMARIO OPERABILE SOTTOPOSTE A CHEMIOTERAPIA PREOPERATORIA
2006 Guarneri, Valentina; Piacentini, F.; Jovic, G.; Frassoldati, A.; Ficarra, G.; Maiorana, A.; Giovannelli, S.; Tazzioli, G.; Natalizi, G.; Mauri, C.; Battista, R.; Canossi, B.; Conte, P. F.
Phase II, randomized trial of preoperative epirubicin-paclitaxel +/- gefitinib with biomarker evaluation in operable breast cancer.
2008 Guarneri, Valentina; Frassoldati, A.; Ficarra, G.; Puglisi, F.; Andreetta, C.; Michelotti, A.; Cresti, N.; Boni, C.; Bisagni, G.; Berardi, R.; Battelli, N.; Santoro, A.; Banna, G.; Bottini, A.; DI BLASIO, B.; Maiorana, Antonino; Piacentini, Federico; Giovannelli, Simona; Jovic, Gordana; Conte, Pierfranco
Preliminary safety data of preoperative chemotherapy plus trastuzumab, lapatinib or both in HER2-positive operable breast cancer
2007 Guarneri, Valentina; Frassoldati, A; Piacentini, Federico; Cagossi, K; Cavanna, L; Michelotti, A; Jovic, Gordana; Giovannelli, Simona; Ficarra, G; Oliva, C; Conte, Pierfranco
Preoperative chemotherapy plus lapatinib or trastuzumab or both in Her2 positive operable breast cancer. EGF109085-LAP106988/CHERLOB Trial.
2008 Guarneri, Valentina; Frassoldati, A; Piacentini, Federico; Jovic, Gordana; Giovannelli, Simona; Oliva, C; Conte, Pierfranco
Prognostic and Predictive Value of Baseline and Posttreatment Molecular Marker Expression in Locally Advanced Rectal Cancer Treated With Neoadjuvant Chemoradiotherapy
2007 Bertolini, Federica; Bengala, C; Losi, L; Pagano, Maria; Iachetta, Francesco; Dealis, Cristina; Jovic, Gordana; Depenni, R; Zironi, S; Falchi, Anna Maria; Luppi, G; Conte, Pierfranco
Prognostic value of Dworak grade of regression (GR) in patients with rectal carcinoma treated with preoperative radiochemotherapy
2006 Losi, Lorena; G., Luppi; M., Gavioli; Iachetta, Francesco; Bertolini, Federica; D'Amico, Roberto; Jovic, Gordana; F., Bertoni; Falchi, Anna Maria; Conte, Pierfranco
PROLIFERATION AND APOPTOSIS BEFORE AND AFTER PRIMARY SYSTEMIC THERAPY FOR OPERABLE BREAST CANCER
2007 Guarneri, V.; Piacentini, F.; Frassoldati, A.; Ficarra, G.; Jovic, G.; Pugliesi, F.; Michelotti, A.; Bisagni, G.; Berardi, R.; Conte, Pf.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A prognostic model based on nodal status and Ki-67 predicts the risk of recurrence and death in breast cancer patients with residual disease after preoperative chemotherapy. | 1-gen-2009 | Guarneri, Valentina; Piacentini, Federico; Ficarra, G; Frassoldati, A; D'Amico, Roberto; Giovannelli, Simona; Maiorana, Antonino; Jovic, Gordana; Conte, Pierfranco | |
| Biomarker expression and survival after primary chemotherapy for breast cancer. | 1-gen-2006 | Guarneri, Valentina; Piacentini, Federico; Jovic, Gordana; Frassoldati, A; Ficarra, G; Giovannelli, Simona; Maur, M; Borghi, F; Vicini, Roberto; Conte, Pierfranco | |
| CHEMOTHERAPY-INDUCED MODULATION OF BIOMARKERS EXPRESSION IN PRIMARY BREAST CANCER PATIENTS TREATED WITH PREOPERATIVE CHEMOTHERAPY | 1-gen-2006 | Guarneri, V.; Piacentini, F.; Frassoldati, A.; Jovic, G.; Ficarra, G.; Maur, M.; Giovannelli, S.; Giardina, D.; Conte, P. F. | |
| CHER LOB Trial: Preoperative chemotherapy plus trastuzumab, lapatinib or both in HER2-positive operable breast cancer--Safety report as per Independent Data Monitoring Committee (IDMC) and preliminary activity data | 1-gen-2008 | Guarneri, Valentina; A., Frassoldati; K., Cagossi; A., Bottini; A., Michelotti; L., Cavanna; Jovic, Gordana; Piacentini, Federico; C., Oliva; Conte, Pierfranco | |
| CHER-LOB: PREOPERATIVE CHEMOTHERAPY PLUS TRASTUZUMAB, LAPATINIB OR BOTH IN HER2-POSITIVE OPERABLE BREAST CANCER – PRELIMINARY SAFETY REPORT WITH FOCUS ON CARDIAC TOLERABILITY | 1-gen-2007 | Guarneri, V.; Frassoldati, A.; Cagossi, K.; Bottini, A.; Cavanna, L.; Michelotti, A.; Jovic, G.; Piacentini, F.; Oliva, C.; Conte, Pf. | |
| Comparison of HER-2 and hormone receptor expression in primary breast cancers and asynchronous paired metastases: impact on patient management | 1-gen-2008 | Guarneri, Valentina; Giovannelli, Simona; Ficarra, G; Bettelli, Stefania Raffaella; Maiorana, Antonino; Piacentini, Federico; Barbieri, Elena; Dieci, Maria Vittoria; D'Amico, Roberto; Jovic, Gordana; Conte, Pierfranco | |
| COMPARISON OF HER-2 STATUS IN PRIMARY BREAST CANCER AND METASTATIC SITES: RESULTS FROM A SINGLE INSTITUTION ANALYSIS | 1-gen-2008 | Guarneri, V.; Giovannelli, S.; Ficarra, G.; Bettelli, S.; Piacentini, F.; Barbieri, E.; Dieci, Mv.; Jovic, G.; Conte, Pf. | |
| Final results of a phase II, double blind, placebo controlled, randomized trial of preoperative chemotherapy +/- gefitinib with biomarker evaluation in operable breast cancer | 1-gen-2006 | Guarneri, Valentina; Frassoldati, A; Ficarra, G; Jovic, Gordana; Puglisi, F; Michelotti, A; Boni, C; Battelli, N; Santoro, A; Conte, Pierfranco | |
| Helicobacter pylori infection andchronic immune thrombocytopenic purpura: long-term results of bacteriumeradication and association with bacterium virulence profiles | 1-gen-2007 | Emilia, Giovanni; Luppi, Mario; Zucchini, Patrizia; Morselli, M; Potenza, Leonardo; Forghieri, Fabio; Volzone, F; Jovic, Gordana; Leonardi, G; Donelli, A; Torelli, Giuseppe | |
| LET-LOB: preoperative letrozole plus lapatinib or placebo in hormone-receptor positive HER2 negative operable breats cancer. Preliminary report of activity and cardiac tolerability | 1-gen-2007 | Frassoldati, A; Guarneri, Valentina; Cagossi, K.; Bottini, A; Cavanna, L; Jovic, Gordana; Piacentini, Federico; Oliva, C; Conte, Pierfranco | |
| Letrozole Versus Letrozole Plus Lapatinib (GW572016) in Hormone-Sensitive, HER2-Negative Operable Breast Cancer: A Double-Blind, Randomized Phase II Study with Biomarker Evaluation (EGF109077-LAP107692/LETLOB) | 1-gen-2008 | Frassoldati, A; Guarneri, Valentina; Piacentini, Federico; Jovic, Gordana; Giovannelli, Simona; Oliva, C; Conte, Pierfranco | |
| Middle turbinate preservation versus middle turbinate resection in endoscopic surgical treatment of nasal polyposis | 1-gen-2008 | Marchioni, Daniele; ALICANDRI CIUFELLI, Matteo; Mattioli, Francesco; Marchetti, Alessio; Jovic, Gordana; Massone, Federica; Presutti, Livio | |
| MODULAZIONE DELL’ESPRESSIONE DI BIOMARCATORI E PROGNOSI IN PAZIENTI AFFETTE DA CARCINOMA MAMMARIO OPERABILE SOTTOPOSTE A CHEMIOTERAPIA PREOPERATORIA | 1-gen-2006 | Guarneri, Valentina; Piacentini, F.; Jovic, G.; Frassoldati, A.; Ficarra, G.; Maiorana, A.; Giovannelli, S.; Tazzioli, G.; Natalizi, G.; Mauri, C.; Battista, R.; Canossi, B.; Conte, P. F. | |
| Phase II, randomized trial of preoperative epirubicin-paclitaxel +/- gefitinib with biomarker evaluation in operable breast cancer. | 1-gen-2008 | Guarneri, Valentina; Frassoldati, A.; Ficarra, G.; Puglisi, F.; Andreetta, C.; Michelotti, A.; Cresti, N.; Boni, C.; Bisagni, G.; Berardi, R.; Battelli, N.; Santoro, A.; Banna, G.; Bottini, A.; DI BLASIO, B.; Maiorana, Antonino; Piacentini, Federico; Giovannelli, Simona; Jovic, Gordana; Conte, Pierfranco | |
| Preliminary safety data of preoperative chemotherapy plus trastuzumab, lapatinib or both in HER2-positive operable breast cancer | 1-gen-2007 | Guarneri, Valentina; Frassoldati, A; Piacentini, Federico; Cagossi, K; Cavanna, L; Michelotti, A; Jovic, Gordana; Giovannelli, Simona; Ficarra, G; Oliva, C; Conte, Pierfranco | |
| Preoperative chemotherapy plus lapatinib or trastuzumab or both in Her2 positive operable breast cancer. EGF109085-LAP106988/CHERLOB Trial. | 1-gen-2008 | Guarneri, Valentina; Frassoldati, A; Piacentini, Federico; Jovic, Gordana; Giovannelli, Simona; Oliva, C; Conte, Pierfranco | |
| Prognostic and Predictive Value of Baseline and Posttreatment Molecular Marker Expression in Locally Advanced Rectal Cancer Treated With Neoadjuvant Chemoradiotherapy | 1-gen-2007 | Bertolini, Federica; Bengala, C; Losi, L; Pagano, Maria; Iachetta, Francesco; Dealis, Cristina; Jovic, Gordana; Depenni, R; Zironi, S; Falchi, Anna Maria; Luppi, G; Conte, Pierfranco | |
| Prognostic value of Dworak grade of regression (GR) in patients with rectal carcinoma treated with preoperative radiochemotherapy | 1-gen-2006 | Losi, Lorena; G., Luppi; M., Gavioli; Iachetta, Francesco; Bertolini, Federica; D'Amico, Roberto; Jovic, Gordana; F., Bertoni; Falchi, Anna Maria; Conte, Pierfranco | |
| PROLIFERATION AND APOPTOSIS BEFORE AND AFTER PRIMARY SYSTEMIC THERAPY FOR OPERABLE BREAST CANCER | 1-gen-2007 | Guarneri, V.; Piacentini, F.; Frassoldati, A.; Ficarra, G.; Jovic, G.; Pugliesi, F.; Michelotti, A.; Bisagni, G.; Berardi, R.; Conte, Pf. |